LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.018
 23.10 84.90 1282 1616 0.7932 0.8939
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 23.10 84.90 1416 1616 0.8761 0.9387
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 24.81 84.90 15 1769 0.0085 -0.3267
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 24.81 84.90 1466 1769 0.8285 0.9159
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 24.81 84.90 1422 1769 0.8036 0.9027
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 24.81 84.90 1527 1769 0.8630 0.9338
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 26.51 84.90 21 1923 0.0109 -0.2668
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 26.51 84.90 1598 1923 0.8309 0.9194
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 26.51 84.90 1510 1923 0.7852 0.8954
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 26.51 84.90 1588 1923 0.8257 0.9167
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 28.21 84.90 32 2091 0.0153 -0.1903
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 28.21 84.90 1714 2091 0.8195 0.9157
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 28.21 84.90 1675 2091 0.8009 0.9062
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 28.21 84.90 1742 2091 0.8329 0.9224
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 29.92 84.90 53 2237 0.0237 -0.0950
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 29.92 84.90 1847 2237 0.8254 0.9203
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 29.92 84.90 1785 2237 0.7977 0.9065
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 29.92 84.90 1835 2237 0.8200 0.9177
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 31.62 84.90 58 2449 0.0237 -0.0755
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 31.62 84.90 2077 2449 0.8479 0.9331
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 31.62 84.90 1968 2449 0.8034 0.9117
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 31.62 84.90 2006 2449 0.8189 0.9193
MN20160318_Q02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 33.32 84.90 82 2722 0.0301 -0.0069
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 33.32 84.90 2243 2722 0.8239 0.9241
MN20160318_Q02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 33.32 84.90 2160 2722 0.7934 0.9096
MN20160318_Q02
G06